Push To Postpone Cannabis Legalization In Germany, France Omits Medical Marijuana Flower & More Euro Weed Updates

Over the last several years, Europe has become more open-minded about medical and recreational marijuana. Here are some of the latest cannabis developments from France, The United Kingdom, and Germany. 

France: No Cannabis Flower In Medical Cannabis Program 

The French National Medicines Safety Agency (ANSM) recently confirmed that cannabis flower will not be included in its generalized medical marijuana program, reported Business Of Cannabis. The announcement provided details about how the new medical marijuana scheme will develop. 

According to the announcement, patients who have taken part in the pilot scheme before March 27, 2024, can continue their treatment as previously, but no new patients will be allowed to join the pilot after this date. New healthcare professionals can take part in the experiment. 

While the initial medical marijuana experiment was supposed to end this March, the country’s Minister for Health Aurélien Rousseau confirmed in October that the program, benefiting some 2,540 patients, will continue. 

On Oct. 23 the government proposed an amendment to the Social Security Financing Bill (PLFSS) concerning medical marijuana (MMJ). This was the first time, medical cannabis law was presented to France’s general medical framework. Under the new proposals, medical cannabis products will be granted a “temporary authorization” for five years, with a possibility of indefinite renewals.

Omitting marijuana flower from the program has caused outrage from some patients, writes the outlet. 

UK: Illegal Weed Market Booms To Estimated $3.3B Annually 

The United Kingdom’s illegal cannabis market is estimated to be worth £2.6 billion ($3.3 billion) per year. Curbing these illicit operations is challenging in the country, mostly due to the high demand for pain relief treatments, writes Proactive Investors. 

According to data from a private cannabis clinic in central London, Mamedica, some 3 million Britons …

Full story available on Benzinga.com